AmpliPhi, C3J reverse merge
AmpliPhi Biosciences Corp. is reverse merging with fellow infectious disease-focused firm C3J Therapeutics Inc. in a stock swap.
- Gene Therapy, Cell Therapy
- Large Molecule
- Full Acquisition
- Includes Contract
- Intra-Biotech Deal
- Payment Includes Stock
- Reverse Acquisition
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.